Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

被引:1125
作者
Darrah, Patricia A.
Patel, Dipti T.
De Luca, Paula M.
Lindsay, Ross W. B.
Davey, Dylan F.
Flynn, Barbara J.
Hoff, Soren T.
Andersen, Peter
Reed, Steven G.
Morris, Sheldon L.
Roederer, Mario
Seder, Robert A.
机构
[1] NIAID, Cellular Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen S, Denmark
[3] Infect Dis Res Inst, Seattle, WA 98104 USA
[4] US FDA, Ctr Biol Evaluat & Res, Lab Mycobacterial Dis & Cellular Immunol, Bethesda, MD 20892 USA
[5] NIAID, Vaccine Res Ctr, ImmunoTechnol Sect, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/nm1592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD4(+) T cells have a crucial role in mediating protection against a variety of pathogens through production of specific cytokines. However, substantial heterogeneity in CD4(+) T-cell cytokine responses has limited the ability to define an immune correlate of protection after vaccination. Here, using multiparameter flow cytometry to assess the immune responses after immunization, we show that the degree of protection against Leishmania major infection in mice is predicted by the frequency of CD4(+) T cells simultaneously producing interferon-gamma, interleukin-2 and tumor necrosis factor. Notably, multifunctional effector cells generated by all vaccines tested are unique in their capacity to produce high amounts of interferon-gamma. These data show that the quality of a CD4(+) T-cell cytokine response can be a crucial determinant in whether a vaccine is protective, and may provide a new and useful prospective immune correlate of protection for vaccines based on T-helper type 1 (T(H)1) cells.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 49 条
  • [1] The success and failure of BCG - implications for a novel tuberculosis vaccine
    Andersen, P
    Doherty, TM
    [J]. NATURE REVIEWS MICROBIOLOGY, 2005, 3 (08) : 656 - 662
  • [2] Rational design of gene-based vaccines
    Barouch, DH
    [J]. JOURNAL OF PATHOLOGY, 2006, 208 (02) : 283 - 289
  • [3] A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity
    Belkaid, Y
    Mendez, S
    Lira, R
    Kadambi, N
    Milon, G
    Sacks, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (02) : 969 - 977
  • [4] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [5] HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
    Betts, Michael R.
    Nason, Martha C.
    West, Sadie M.
    De Rosa, Stephen C.
    Migueles, Stephen A.
    Abraham, Jonathan
    Lederman, Michael M.
    Benito, Jose M.
    Goepfert, Paul A.
    Connors, Mark
    Roederer, Mario
    Koup, Richard A.
    [J]. BLOOD, 2006, 107 (12) : 4781 - 4789
  • [6] Genetic susceptibility to leishmanial infections: Studies in mice and man
    Blackwell, JM
    [J]. PARASITOLOGY, 1996, 112 : S67 - S74
  • [7] EXPERIMENTAL APPROACHES TO MECHANISMS OF PROTECTION AND PATHOGENESIS IN M. TUBERCULOSIS INFECTION
    BLOOM, BR
    FLYNN, J
    MCDONOUGH, K
    KRESS, Y
    CHAN, J
    [J]. IMMUNOBIOLOGY, 1994, 191 (4-5) : 526 - 536
  • [8] TUMOR NECROSIS FACTOR-ALPHA IN COMBINATION WITH INTERFERON-GAMMA, BUT NOT WITH INTERLEUKIN-4 ACTIVATES MURINE MACROPHAGES FOR ELIMINATION OF LEISHMANIA-MAJOR AMASTIGOTES
    BOGDAN, C
    MOLL, H
    SOLBACH, W
    ROLLINGHOFF, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (05) : 1131 - 1135
  • [9] HETEROGENEITY OF SINGLE-CELL CYTOKINE GENE-EXPRESSION IN CLONAL T-CELL POPULATIONS
    BUCY, RP
    PANOSKALTSISMORTARI, A
    HUANG, GQ
    LI, JM
    KARR, L
    ROSS, M
    RUSSELL, JH
    MURPHY, KM
    WEAVER, CT
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1251 - 1262
  • [10] Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches
    Constant, SL
    Bottomly, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 297 - 322